Publications

Export 5 results:
Author Title Type [ Year(Asc)]
Filters: Author is de la Fuente-Sandoval, Camilo  [Clear All Filters]
2022
Reyes-Madrigal F, Guma E, León-Ortiz P, Gómez-Cruz G, Mora-Durán R, Graff-Guerrero A, Kegeles LS, Chakravarty MM, de la Fuente-Sandoval C.  2022.  Striatal glutamate, subcortical structure and clinical response to first-line treatment in first-episode psychosis patients.. Prog Neuropsychopharmacol Biol Psychiatry. 113:110473.
2021
Hui SCN, Mikkelsen M, Zöllner HJ, Ahluwalia V, Alcauter S, Baltusis L, Barany DA, Barlow LR, Becker R, Berman JI et al..  2021.  Frequency drift in MR spectroscopy at 3T.. Neuroimage. 241:118430.
2017
Winterburn JL, Voineskos AN, Devenyi GA, Plitman E, de la Fuente-Sandoval C, Bhagwat N, Graff-Guerrero A, Knight J, Chakravarty MM.  2017.  Can we accurately classify schizophrenia patients from healthy controls using magnetic resonance imaging and machine learning? A multi-method and multi-dataset study. Schizophr Res.
2016
Plitman E, Patel R, Chung JKu, Pipitone J, Chavez S, Reyes-Madrigal F, Gómez-Cruz G, León-Ortiz P, Chakravarty MM, de la Fuente-Sandoval C et al..  2016.  Glutamatergic Metabolites, Volume and Cortical Thickness in Antipsychotic-Naive Patients with First-Episode Psychosis: Implications for Excitotoxicity.. Neuropsychopharmacology. 41(10):2606-13.
2014
Plitman E, Nakajima S, de la Fuente-Sandoval C, Gerretsen P, Chakravarty MM, Kobylianskii J, Chung JKu, Caravaggio F, Iwata Y, Remington G et al..  2014.  Glutamate-mediated excitotoxicity in schizophrenia: a review.. Eur Neuropsychopharmacol. 24(10):1591-605.